Pharmacokinetics and pharmacodynamics of alirocumab in patients with autosomal dominant hypercholesterolemia associated with PCSK9 gain-of-function or ApoB loss-of-function mutations

被引：0

作者：

Hopkins, P. N. ^{[1
]}

Krempf, M. ^{[2
]}

Bruckert, E. ^{[3
]}

Luc, G. ^{[4
]}

Donahue, S. ^{[5
]}

Yang, F. ^{[5
]}

Zhang, Y. ^{[5
]}

Dicioccio, A. T. ^{[5
]}

机构：

[1] Univ Utah, Sch Med, Salt Lake City, UT USA

[2] CHU Nantes, Hop Nord Laennec, St Herblain, France

[3] Hosp Pitie Salpetriere, Paris, France

[4] Univ Lille 2, Lille, France

[5] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA

来源：

EUROPEAN HEART JOURNAL | 2018年 / 39卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

352

引用

页码：49 / 49

页数：1

共 50 条

[41] De novo gain-of-function and loss-of-function mutations of SCN8A in patients with intellectual disabilities and epilepsy
Blanchard, Maxime G.
Willemsen, Marjolein H.
Walker, Jaclyn B.
Dib-Hajj, Sulayman D.
Waxman, Stephen G.
Jongmans, Marjolijn C. J.
Kleefstra, Tjitske
van de Warrenburg, Bart P.
Praamstra, Peter
Nicolai, Joost
Yntema, Helger G.
Bindels, Rene J. M.
Meisler, Miriam H.
Kamsteeg, Erik-Jan
JOURNAL OF MEDICAL GENETICS, 2015, 52 (05) : 330 - 337
[42] Variations in SREBP2 and PCSK9 genes in autosomal dominant hypercholesterolemic patients lacking pathogenic mutations in LDLR and APOB genes
Blesa, S.
Garcia, A. B.
Martinez, S.
Gonzalez, V.
Ascaso, J.
Carmena, R.
Real, J. T.
Chaves, F. J.
ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 135 - 135
[43] Prediction of gain-of-function and loss-of-function mutations using Combined Annotation Dependent Depletion (CADD)
Ghosh, A.
Navarini, A.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : S232 - S232
[44] Effect of Loss-of-Function Genetic Variants in PCSK9 on Glycemic Traits, Neurocognitive Impairment, and Hepatobiliary Function
Ghouse, Jonas
Ahlberg, Gustav
Bundgaard, Henning
Olesen, Morten S.
DIABETES CARE, 2022, 45 (01) : 251 - 254
[45] Genotypic and phenotypic features in homozygous familial hypercholesterolemia caused by proprotein convertase subtilisin/kexin type 9 (PCSK9) gain-of-function mutation
Mabuchi, Hiroshi
Nohara, Atsushi
Noguchi, Tohru
Kobayashi, Junji
Kawashiri, Masa-aki
Inoue, Takeshi
Mori, Mika
Tada, Hayato
Nakanishi, Chiaki
Yagi, Kunimasa
Yamagishi, Masakazu
Ueda, Kousei
Takegoshi, Tadayoshi
Miyamoto, Susumu
Inazu, Akihiro
Koizumi, Junji
ATHEROSCLEROSIS, 2014, 236 (01) : 54 - 61
[46] GENOTYPIC AND PHENOTYPIC FEATURES IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA CAUSED BY PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) GAIN-OF-FUNCTION MUTATION
Mabuchi, H.
Noguchi, T.
Kobayashi, J.
Kawashiri, M.
Inoue, T.
Mori, M.
Tada, H.
Nakanishi, C.
Yagi, K.
Yamagishi, M.
Ueda, K.
Takegoshi, T.
Miyamoto, S.
Inazu, A.
Koizumi, J.
ATHEROSCLEROSIS, 2014, 235 (02) : E98 - E99
[47] Clinical phenotypes of patients with GABRG2 loss-of-function and gain-of-function variants
Rossi, A.
Lin, S. X.
Moller, R. S.
Gardella, E.
Absalom, N. L.
Ahring, P. K.
Rubboli, G.
EPILEPSIA, 2023, 64 : 32 - 33
[48] Identification and in vitro characterization of two new PCSK9 Gain of Function variants found in patients with Familial Hypercholesterolemia
Maria Donata Di Taranto
Asier Benito-Vicente
Carola Giacobbe
Kepa Belloso Uribe
Paolo Rubba
Aitor Etxebarria
Ornella Guardamagna
Marco Gentile
Cesar Martín
Giuliana Fortunato
Scientific Reports, 7
[49] Identification and in vitro characterization of two new PCSK9 Gain of Function variants found in patients with Familial Hypercholesterolemia
Di Taranto, Maria Donata
Benito-Vicente, Asier
Giacobbe, Carola
Uribe, Kepa Belloso
Rubba, Paolo
Etxebarria, Aitor
Guardamagna, Ornella
Gentile, Marco
Martin, Cesar
Fortunato, Giuliana
SCIENTIFIC REPORTS, 2017, 7
[50] PCSK9 LOSS-OF-FUNCTION RESULTS IN CARDIAC DYSFUNCTION IN A JUVENILE MURINE MODEL OF SEPSIS
Atreya, Mihir R.
Whitacre, Brynne
Wong, Hector
SHOCK, 2020, 53 : 104 - 104

← 1 2 3 4 5 →